• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MEM 0.00% 0.6¢

MEMPHASYS LIMITED. - Charts / Financials

Memphasys Limited is an Australia-based reproductive biotechnology company. The Company... Memphasys Limited is an Australia-based reproductive biotechnology company. The Company is engaged in developing medical devices, diagnostics, and media with application to assisted reproductive technology (ART) in humans and animals. The Company's product pipeline includes Felix, RoXsta, and AI-Port. Its advanced product, the Felix System, is a patented automated device for quickly and gently separating sperm from a semen sample for use in ART procedures. The Felix device consists of two main components: a console, which supplies electrical power, and a sterile disposable cartridge for sperm isolation and selection. RoXsta is an in-vitro diagnostic device that assesses semen and other bodily fluids for oxidative stress load. RoXsta also has an application as part of a suite of products that can support the animal industry. AI-Port has been developed for the purpose of maintaining the viability of livestock semen for up to seven days at a temperature range of 22 - 25 degrees Celsius.More

refresh Created with Sketch. REFRESH
Last update - 11.48am 25/11/2024 (20 minute delay) ?
Day
Open 0.6¢   Day High 0.6¢   Day Low 0.6¢
Daily Volume 44194
Bids   Sellers
Number Price Volume   Number Price Volume
8 0.5¢ 9530299   8 0.6¢ 11345702

Directors & Senior Management

Dr. David Ali Chief Executive Officer, Executive Director
Mr. Pablo Neyertz Director of Finance
Prof. John Aitken Research Director
Assoc. Prof. Hassan Bakos Director of Operations
Mr. Nick Gorring Operations Manager
Mr. Andrew Metcalfe Company Secretary
Mr. Robert Cooke Non-Executive Independent Chairman of the Board
Mr. Michael Atkins Independent Non-Executive Director
Mr. Paul Martin Wright Non-Executive Independent Director
Dr. David Ali Chief Executive Officer, Executive Director
Mr. Pablo Neyertz Director of Finance
Prof. John Aitken Research Director
Assoc. Prof. Hassan Bakos Director of Operations
Mr. Nick Gorring Operations Manager
Mr. Andrew Metcalfe Company Secretary
Mr. Robert Cooke Non-Executive Independent Chairman of the Board
Mr. Michael Atkins Independent Non-Executive Director
Mr. Paul Martin Wright Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
0.6¢
Change
0.000(0.00%)
Mkt cap ! $13.00M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $265 44.19K

Buyers (Bids)

No. Vol. Price($)
8 9530299 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 11345702 8
View Market Depth
Last trade - 10.04am 25/11/2024 (20 minute delay) ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.